Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06987084

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers

A Novel Treatment for Recurrent Kidney Stones

Status
Enrolling By Invitation
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Indra Gupta · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this randomized placebo-controlled double-blind crossover clinical trial is to test the ability of a traditional tea made from the leaf of the Bryophyllum pinnatum (B. pinnatum) plant in decreasing urinary calcium content in patients with recurrent calcium-based kidney stones.

Detailed description

Background and Rationale: Kidney stones are hard deposits that consist of calcium complexed with phosphate or oxalate, thus, high urinary calcium content is a major risk factor. The precipitation of calcium can arise from various mechanisms including the aggregation of urinary calcium crystals from impaired transport along the nephron, reduced urinary inhibitors (e.g. citrate), and increased oxidative stress and inflammation. Large stones can block the drainage system of the kidney, causing acute severe pain and inflammation. Recurrent kidney stones can lead to sustained inflammation resulting in a progressive loss of renal function. As the global incidence and economic burden continues to rise there is a undisputed medical need to find preventative measures. Thiazide diuretics have been fundamental in pharmacological recurrence prevention for the past 60 years. The recent NOSTONE trial (NCT03057431) revealed that the most widely prescribed and best studied thiazide, hydrochlorothiazide, did not reduce the incidence of stone recurrence. There remain significant barriers to kidney stone treatment including high treatment costs, side effects, and the difficulty in achieving long-term dietary and lifestyle changes. Therefore, many patients risk recurrent episodes. New innovative approaches are needed to prevent kidney stone formation. The leaves of Bryophyllum pinnatum are used to treat a variety of ailments, including the prevention and treatment of kidney stones in various formulations. In a rat kidney stone model, aqueous, alcoholic, and non-alcoholic extracts of B. pinnatum leaves prevented the formation and reduced the size of kidney stones. In an uncontrolled trial, patients with renal stones treated with B. pinnatum juice either passed their stones or showed a reduction in the size of their stones. Despite its established use in other countries, B. pinnatum tea has not undergone rigorous scientific or clinical evaluation. Our lab characterized and standardized the formulation of the tea which revealed anti-urolithiatic activity along with antioxidant and anti-inflammatory properties. A combination of these effects may be what is beneficial in the prevention of recurrent kidney stones.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTBryophyllum pinnatum tea24 g of B. pinnatum leaves boiled in 250 mL of water for 61 minutes sweetened with 1/2 teaspoon of sugar
COMBINATION_PRODUCTPlacebo tea250 mL of water boiled with 3 g of wheat-bran for 5 minutes sweetened with 1/2 teaspoon of sugar

Timeline

Start date
2024-11-07
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-05-23
Last updated
2025-05-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06987084. Inclusion in this directory is not an endorsement.

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers (NCT06987084) · Clinical Trials Directory